Maxipime - 0409-0219-01 - (CEFEPIME HYDROCHLORIDE)

Alphabetical Index


Drug Information of Maxipime

Product NDC: 0409-0219
Proprietary Name: Maxipime
Non Proprietary Name: CEFEPIME HYDROCHLORIDE
Active Ingredient(s): 1    g/1 & nbsp;   CEFEPIME HYDROCHLORIDE
Administration Route(s): INTRAMUSCULAR; INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Maxipime

Product NDC: 0409-0219
Labeler Name: Hospira, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA050679
Marketing Category: NDA
Start Marketing Date: 20121227

Package Information of Maxipime

Package NDC: 0409-0219-01
Package Description: 10 VIAL in 1 CARTON (0409-0219-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL

NDC Information of Maxipime

NDC Code 0409-0219-01
Proprietary Name Maxipime
Package Description 10 VIAL in 1 CARTON (0409-0219-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Product NDC 0409-0219
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name CEFEPIME HYDROCHLORIDE
Dosage Form Name INJECTION, POWDER, FOR SOLUTION
Route Name INTRAMUSCULAR; INTRAVENOUS
Start Marketing Date 20121227
Marketing Category Name NDA
Labeler Name Hospira, Inc.
Substance Name CEFEPIME HYDROCHLORIDE
Strength Number 1
Strength Unit g/1
Pharmaceutical Classes Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient]

Complete Information of Maxipime


General Information